Page last updated: 2024-12-06
methoxine
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
methoxine: oxa-analog of methionine; RN given refers to parent cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 18713 |
SCHEMBL ID | 524526 |
MeSH ID | M0114274 |
Synonyms (28)
Synonym |
---|
4385-91-5 |
butyric acid, 2-amino-4-methoxy- |
methoxine |
a 7572 |
nsc-9325 |
homoserine, o-methyl- |
nsc9325 |
methoxinine |
AKOS000195201 |
2-amino-4-methoxybutanoic acid |
2-amino-4-methoxy-butyric acid |
EN300-62236 |
einecs 224-496-5 |
2-amino-4-methoxybutyric acid |
nsc 9325 |
butyric acid, 2-amino-4-methoxy-, dl- |
o-methylhomoserine |
dl-2-amino-4-methoxybutanoic acid |
oxymethionine |
AKOS022482961 |
SCHEMBL524526 |
KFHRMMHGGBCRIV-UHFFFAOYSA-N |
gamma-methoxy-alpha-amino butyric acid |
F8887-3926 |
DTXSID40884068 |
STARBLD0013336 |
CS-0065907 |
Z317025018 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (8)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 5 (62.50) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 33.21
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (33.21) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |